SARS-CoV2 antibody tests: not suited for individual diagnosis?

This is no good message for policymakers willing to relax social distancing measures based on immunity passports or antibody titers against the...

Illumina and Epidarex Capital invest in post-Brexit UK

Epidarex Capital’s (Edinburgh) oversubscribed £102m UK life sciences VC fund was backed by a £50m investment from the British Business Bank, who is...

Hyloris Pharmaceuticals prepared to go public

Reformulation specialist Hyloris Pharmaceuticals SA  wants to go public on the regulated market of Euronext Brussels. The company reformulates...

BioGeneration Ventures closes BGV IV Fund at €105m

Investors into the oversubscribed BVG IV gathered existing actors — such as Bristol Myers Squibb, the European Investment Fund, and Schroder Adveq —...

Evotec partners with Secarna to develop LNA drugs

Third generation Locked Nucleic Acids (LNAs) target pathogenic changes in gene expression. Secarna and Evotec have now formed a partnership aimed at...

New algorithm predicts rheumatoid arthritis

The team of Dutch and US researchers writes in Science Translational Medicine that they have developed a new diagnostic tool that can ease diagnosis...

Evotec receives $8.4m CARB-X funding

Evotec SE has licensed a research programme from Resolute Therapeutics Inc currently in lead optimisation. Under the agreement, Evotec will continue...